Insider filing · ALNY
Colleen F Reitan
Director
profile →
Alnylam Pharmaceuticals, Inc.
ALNY · Healthcare · 57 filings in 24 months
ticker →
Colleen F Reitan sold $8.4M of Alnylam Pharmaceuticals (ALNY)
Executed Sep 9 2025, disclosed Sep 11 2025, 2 days later.
Value, as filed
$8.4M
17,975 sh across 15 lots
Executed
Sep 9 2025
the trade date, as filed
Disclosed
Sep 11 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
CRColleen F Reitan (Director) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Alnylam Pharmaceuticals, Inc. (ALNY). The largest single filing was $8.4M of ALNY (17,975 sh across 15 lots, as filed), executed Sep 9 2025.
The name
ALNYHealthcare · Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→